Back to results
US 8,895,497 B2Granted
Cathepsin S inhibitors
AssigneesDcb-USA LLC, National Tsing Hua University, National Health Research Institutes
InventorsChun-Cheng Lin, Wun-Shaing Wayne Chang, Biing-Jiun Uang, Jang-Yang Chang, Jo-Chun Chen, Hsing-Pang Hsieh
Life of this patent
Estimating the term…
Abstract
Cathepsin S inhibitors having formula (I), (II), (III) or (IV) as shown in the specification. These inhibitors can be used to treat cancer and autoimmune/inflammatory diseases.
Claims14
A compound of formula (I):
- wherein
- R1 is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, ORa, SRa, NRaRb, N(Ra)C(O)Rb, N(Ra)C(O)ORb, C(O)Ra, COORa, OC(O)Ra, C(S)Ra, C(O)NRaRb, C(S)NRaRb, N(Ra)C(S)Rb, or N(Ra)N(Rb)C(O)Rc, in which each of Ra, Rb, and Rc, independently, is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, or heteroaryl, or Ra and Rb together with the nitrogen atom or nitrogen atoms to which they are attached form heterocycloalkyl, heterocycloalkenyl, or heteroaryl;
- each of R2 and R3, independently, is H, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, or alkyl optionally substituted with cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, or heteroaryl;
- and
- each of R4 and R5, independently, is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, or heteroaryl, or R4 and R5 together with the nitrogen atom to which they are attached form heterocycloalkyl, heterocycloalkenyl, or heteroaryl.
2 more elements
Dependencies are inferred from the claim text.